Daniel H Bedinger

6PUBLICATIONS
99CO-AUTHORS
Bioinformatic methods developmentInnate immunityMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 20, 2026
A blinded, prospective benchmark of in silico antibody discovery anchored to experimental affinity and developability.

|Jul 02, 2024
Characterization of two affinity matured Anti-Yersinia pestis F1 human antibodies with medical countermeasure potential.

Nileena Velappan, Sergei S Biryukov, Nathaniel O Rill

|Sep 23, 2021
Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study.

Kathryn M Hastie, Haoyang Li, Daniel Bedinger

|Mar 06, 2020
Assessing the binding properties of the anti-PD-1 antibody landscape using label-free biosensors.

Michael E Brown, Daniel Bedinger, Asparouh Lilov

|Jan 24, 2015
Differential pathway coupling of the activated insulin receptor drives signaling selectivity by XMetA, an allosteric partial agonist antibody.

Daniel H Bedinger, Ira D Goldfine, John A Corbin

Pageof 1

Frequent Collaborators

2 joint publications

Andrew B Ward

2 joint publications

Shipra Malhotra

2 joint publications

Olivia M Swanson

2 joint publications

Pietro Sormanni